Eintrag weiter verarbeiten
Buchumschlag von Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
Verfügbar über Open Access

Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: BioMed Research International
Personen und Körperschaften: Loibl, Markus, Lang, Siegmund, Dendl, Lena-Marie, Nerlich, Michael, Angele, Peter, Gehmert, Sebastian, Huber, Michaela
In: BioMed Research International, 2016, 2016, S. 1-6
Medientyp: E-Article
Sprache: Englisch
veröffentlicht:
Hindawi Limited
Schlagwörter:
author_facet Loibl, Markus
Lang, Siegmund
Dendl, Lena-Marie
Nerlich, Michael
Angele, Peter
Gehmert, Sebastian
Huber, Michaela
Loibl, Markus
Lang, Siegmund
Dendl, Lena-Marie
Nerlich, Michael
Angele, Peter
Gehmert, Sebastian
Huber, Michaela
author Loibl, Markus
Lang, Siegmund
Dendl, Lena-Marie
Nerlich, Michael
Angele, Peter
Gehmert, Sebastian
Huber, Michaela
spellingShingle Loibl, Markus
Lang, Siegmund
Dendl, Lena-Marie
Nerlich, Michael
Angele, Peter
Gehmert, Sebastian
Huber, Michaela
BioMed Research International
Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
General Immunology and Microbiology
General Biochemistry, Genetics and Molecular Biology
General Medicine
author_sort loibl, markus
spelling Loibl, Markus Lang, Siegmund Dendl, Lena-Marie Nerlich, Michael Angele, Peter Gehmert, Sebastian Huber, Michaela 2314-6133 2314-6141 Hindawi Limited General Immunology and Microbiology General Biochemistry, Genetics and Molecular Biology General Medicine http://dx.doi.org/10.1155/2016/9262909 <jats:p>A positive effect of intra-articular platelet-rich plasma (PRP) injection has been discussed for osteoarthritic joint conditions in the last years. The purpose of this study was to evaluate PRP injection into the trapeziometacarpal (TMC) joint. We report about ten patients with TMC joint osteoarthritis (OA) that were treated with 2 intra-articular PRP injections 4 weeks apart. PRP was produced using the Double Syringe System (Arthrex Inc., Naples, Florida, USA). A total volume of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mn fontstyle="italic">1.47</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.25</mml:mn></mml:math> mL PRP was injected at the first injection and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn fontstyle="italic">1.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.41</mml:mn></mml:math> mL at the second injection, depending on the volume capacity of the joint. Patients were evaluated using VAS, strength measures, and the Mayo Wrist score and DASH score after 3 and 6 months. VAS significantly decreased from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn fontstyle="italic">6.2</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn fontstyle="italic">5.4</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.2</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mi>P</mml:mi><mml:mo>&lt;</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). The DASH score was unaffected; however, the Mayo Wrist score significantly improved from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn fontstyle="italic">46.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">18.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn fontstyle="italic">67.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">19.0</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). Grip was unaffected, whereas pinch declined from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn fontstyle="italic">6.02</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.99</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mn fontstyle="italic">3.96</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.77</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11"><mml:mi>P</mml:mi><mml:mo>&lt;</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). We did not observe adverse events after the injection of PRP, except one occurrence of a palmar wrist ganglion, which resolved without treatment. PRP injection for symptomatic TMC OA is a reasonable therapeutic option in early stages TMC OA and can be performed with little to no morbidity.</jats:p> Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study BioMed Research International
doi_str_mv 10.1155/2016/9262909
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE2LzkyNjI5MDk
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE2LzkyNjI5MDk
institution DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
imprint Hindawi Limited, 2016
imprint_str_mv Hindawi Limited, 2016
issn 2314-6133
2314-6141
issn_str_mv 2314-6133
2314-6141
language English
mega_collection Hindawi Limited (CrossRef)
match_str loibl2016leukocytereducedplateletrichplasmatreatmentofbasalthumbarthritisapilotstudy
publishDateSort 2016
publisher Hindawi Limited
recordtype ai
record_format ai
series BioMed Research International
source_id 49
title Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_unstemmed Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_full Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_fullStr Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_full_unstemmed Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_short Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_sort leukocyte-reduced platelet-rich plasma treatment of basal thumb arthritis: a pilot study
topic General Immunology and Microbiology
General Biochemistry, Genetics and Molecular Biology
General Medicine
url http://dx.doi.org/10.1155/2016/9262909
publishDate 2016
physical 1-6
description <jats:p>A positive effect of intra-articular platelet-rich plasma (PRP) injection has been discussed for osteoarthritic joint conditions in the last years. The purpose of this study was to evaluate PRP injection into the trapeziometacarpal (TMC) joint. We report about ten patients with TMC joint osteoarthritis (OA) that were treated with 2 intra-articular PRP injections 4 weeks apart. PRP was produced using the Double Syringe System (Arthrex Inc., Naples, Florida, USA). A total volume of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mn fontstyle="italic">1.47</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.25</mml:mn></mml:math> mL PRP was injected at the first injection and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn fontstyle="italic">1.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.41</mml:mn></mml:math> mL at the second injection, depending on the volume capacity of the joint. Patients were evaluated using VAS, strength measures, and the Mayo Wrist score and DASH score after 3 and 6 months. VAS significantly decreased from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn fontstyle="italic">6.2</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn fontstyle="italic">5.4</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.2</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mi>P</mml:mi><mml:mo>&lt;</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). The DASH score was unaffected; however, the Mayo Wrist score significantly improved from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn fontstyle="italic">46.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">18.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn fontstyle="italic">67.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">19.0</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). Grip was unaffected, whereas pinch declined from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn fontstyle="italic">6.02</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.99</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mn fontstyle="italic">3.96</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.77</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11"><mml:mi>P</mml:mi><mml:mo>&lt;</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). We did not observe adverse events after the injection of PRP, except one occurrence of a palmar wrist ganglion, which resolved without treatment. PRP injection for symptomatic TMC OA is a reasonable therapeutic option in early stages TMC OA and can be performed with little to no morbidity.</jats:p>
container_start_page 1
container_title BioMed Research International
container_volume 2016
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792341401002835972
geogr_code not assigned
last_indexed 2024-03-01T16:19:19.087Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Leukocyte-Reduced+Platelet-Rich+Plasma+Treatment+of+Basal+Thumb+Arthritis%3A+A+Pilot+Study&rft.date=2016-01-01&genre=article&issn=2314-6141&volume=2016&spage=1&epage=6&pages=1-6&jtitle=BioMed+Research+International&atitle=Leukocyte-Reduced+Platelet-Rich+Plasma+Treatment+of+Basal+Thumb+Arthritis%3A+A+Pilot+Study&aulast=Huber&aufirst=Michaela&rft_id=info%3Adoi%2F10.1155%2F2016%2F9262909&rft.language%5B0%5D=eng
SOLR
_version_ 1792341401002835972
author Loibl, Markus, Lang, Siegmund, Dendl, Lena-Marie, Nerlich, Michael, Angele, Peter, Gehmert, Sebastian, Huber, Michaela
author_facet Loibl, Markus, Lang, Siegmund, Dendl, Lena-Marie, Nerlich, Michael, Angele, Peter, Gehmert, Sebastian, Huber, Michaela, Loibl, Markus, Lang, Siegmund, Dendl, Lena-Marie, Nerlich, Michael, Angele, Peter, Gehmert, Sebastian, Huber, Michaela
author_sort loibl, markus
container_start_page 1
container_title BioMed Research International
container_volume 2016
description <jats:p>A positive effect of intra-articular platelet-rich plasma (PRP) injection has been discussed for osteoarthritic joint conditions in the last years. The purpose of this study was to evaluate PRP injection into the trapeziometacarpal (TMC) joint. We report about ten patients with TMC joint osteoarthritis (OA) that were treated with 2 intra-articular PRP injections 4 weeks apart. PRP was produced using the Double Syringe System (Arthrex Inc., Naples, Florida, USA). A total volume of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mn fontstyle="italic">1.47</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.25</mml:mn></mml:math> mL PRP was injected at the first injection and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn fontstyle="italic">1.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.41</mml:mn></mml:math> mL at the second injection, depending on the volume capacity of the joint. Patients were evaluated using VAS, strength measures, and the Mayo Wrist score and DASH score after 3 and 6 months. VAS significantly decreased from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn fontstyle="italic">6.2</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn fontstyle="italic">5.4</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.2</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mi>P</mml:mi><mml:mo>&lt;</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). The DASH score was unaffected; however, the Mayo Wrist score significantly improved from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn fontstyle="italic">46.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">18.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn fontstyle="italic">67.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">19.0</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). Grip was unaffected, whereas pinch declined from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn fontstyle="italic">6.02</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.99</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mn fontstyle="italic">3.96</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.77</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11"><mml:mi>P</mml:mi><mml:mo>&lt;</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). We did not observe adverse events after the injection of PRP, except one occurrence of a palmar wrist ganglion, which resolved without treatment. PRP injection for symptomatic TMC OA is a reasonable therapeutic option in early stages TMC OA and can be performed with little to no morbidity.</jats:p>
doi_str_mv 10.1155/2016/9262909
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE2LzkyNjI5MDk
imprint Hindawi Limited, 2016
imprint_str_mv Hindawi Limited, 2016
institution DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14
issn 2314-6133, 2314-6141
issn_str_mv 2314-6133, 2314-6141
language English
last_indexed 2024-03-01T16:19:19.087Z
match_str loibl2016leukocytereducedplateletrichplasmatreatmentofbasalthumbarthritisapilotstudy
mega_collection Hindawi Limited (CrossRef)
physical 1-6
publishDate 2016
publishDateSort 2016
publisher Hindawi Limited
record_format ai
recordtype ai
series BioMed Research International
source_id 49
spelling Loibl, Markus Lang, Siegmund Dendl, Lena-Marie Nerlich, Michael Angele, Peter Gehmert, Sebastian Huber, Michaela 2314-6133 2314-6141 Hindawi Limited General Immunology and Microbiology General Biochemistry, Genetics and Molecular Biology General Medicine http://dx.doi.org/10.1155/2016/9262909 <jats:p>A positive effect of intra-articular platelet-rich plasma (PRP) injection has been discussed for osteoarthritic joint conditions in the last years. The purpose of this study was to evaluate PRP injection into the trapeziometacarpal (TMC) joint. We report about ten patients with TMC joint osteoarthritis (OA) that were treated with 2 intra-articular PRP injections 4 weeks apart. PRP was produced using the Double Syringe System (Arthrex Inc., Naples, Florida, USA). A total volume of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mn fontstyle="italic">1.47</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.25</mml:mn></mml:math> mL PRP was injected at the first injection and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn fontstyle="italic">1.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.41</mml:mn></mml:math> mL at the second injection, depending on the volume capacity of the joint. Patients were evaluated using VAS, strength measures, and the Mayo Wrist score and DASH score after 3 and 6 months. VAS significantly decreased from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn fontstyle="italic">6.2</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn fontstyle="italic">5.4</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.2</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mi>P</mml:mi><mml:mo>&lt;</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). The DASH score was unaffected; however, the Mayo Wrist score significantly improved from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn fontstyle="italic">46.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">18.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn fontstyle="italic">67.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">19.0</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). Grip was unaffected, whereas pinch declined from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn fontstyle="italic">6.02</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.99</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mn fontstyle="italic">3.96</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.77</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11"><mml:mi>P</mml:mi><mml:mo>&lt;</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). We did not observe adverse events after the injection of PRP, except one occurrence of a palmar wrist ganglion, which resolved without treatment. PRP injection for symptomatic TMC OA is a reasonable therapeutic option in early stages TMC OA and can be performed with little to no morbidity.</jats:p> Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study BioMed Research International
spellingShingle Loibl, Markus, Lang, Siegmund, Dendl, Lena-Marie, Nerlich, Michael, Angele, Peter, Gehmert, Sebastian, Huber, Michaela, BioMed Research International, Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study, General Immunology and Microbiology, General Biochemistry, Genetics and Molecular Biology, General Medicine
title Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_full Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_fullStr Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_full_unstemmed Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_short Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
title_sort leukocyte-reduced platelet-rich plasma treatment of basal thumb arthritis: a pilot study
title_unstemmed Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
topic General Immunology and Microbiology, General Biochemistry, Genetics and Molecular Biology, General Medicine
url http://dx.doi.org/10.1155/2016/9262909